Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of ...

Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth $11.3 billion, one of the largest acquisitions in Minnesota history. The sale follows investor pressure on Minneapolis-based Bio-Techne, ...

-- Round led by Pfizer Ventures, with participation from Deep Track Capital, GV, and founding investor, Aditum Bio -- --LBL-051’s ability to reset the immune system is supported by recent preclinical ...

An under-the-radar Bay Area biotech has brought in a $190 million series B with the goal of hatching a clutch of new companies to fly its drug candidates forward. Patient Square Capital led the ...

SAN FRANCISCO--(BUSINESS WIRE)--Osanni Bio LLC (“Osanni” or “the Company”), a development-stage therapeutics platform reinventing discovery and development of new medicines, today announced the close ...

Back at the Yale library that holds his archive, the low-key creator of “Doonesbury” reunites with the journalist who pieced together his life story. By Pamela Newton When Garry Trudeau first started ...

Explore the life and legacy of notable Black scholar and civil rights pioneer W.E.B. Du Bois. From his birth, just five years after the Emancipation Proclamation; to his death, on the eve of the March ...

Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...

“Why her?” the journalist Mark Oppenheimer writes toward the end of his first biography, “Judy Blume: A Life.” “What is it about Judy and her work that won her so many millions of fans?” Partly talent ...

The B&O Railroad Museum on Jan. 12 unveiled the restored American Freedom Train No. 1 (AFT No. 1) in honor of the 250th anniversary of America. AFT No. 1 was one of three locomotives that powered the ...

See more of our coverage in your search results. Add The New York Post on Google Most people don’t spare a thought for their blood type unless they’re in need of a transfusion — but could yours hold ...

Curi Bio’s ribbon cutting in April 2025 for its new headquarters on Seattle’s waterfront. Elliot Fisher, co-founder and chief business officer, cuts the ribbon with a sword while CEO Nicholas Geisse ...